MSLN and neoplasm: There was no significant difference between these groups in age, tumour histology, tumour debulking status, or chemotherapeutic regimens, which shows that mesothelin is overexpressed in tumours with worse outcome and is suggestive of its independently preventive role in ovarian tumour progression.